On August 22, AdvaMed submitted comments to CMS on the CY 2023 End Stage Renal Disease (ESRD) Prospective Payment System (PPS). In this letter, AdvaMed urged CMS to address barriers to patient dialysis modality choice, increase the use of telehealth and remote monitoring for ESRD patients, and refine the Transitional Payment for Innovative Equipment and Supplies (TPNIES) Program.
For more information on AdvaMed’s efforts around end-stage renal disease, please contact Kirsten Tullia.